Piperidine-ether based hNK1 antagonists 1: Determination of the relative and absolute stereochemical requirements
暂无分享，去创建一个
[1] P. Thadeio,et al. Synthesis of (±)-CP-99994: A highly potent substance P antagonist , 1993 .
[2] P. Thadeio,et al. Discovery of a potent substance P antagonist: recognition of the key molecular determinant. , 1992, Journal of medicinal chemistry.
[3] J. Lowe,et al. The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst. , 1992, Journal of medicinal chemistry.
[4] M. Moskowitz. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. , 1992, Trends in pharmacological sciences.
[5] J. Lowe,et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. , 1991, Science.
[6] R. Snyderman,et al. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. , 1989, Biochemical and biophysical research communications.
[7] A. Gołębiowski,et al. Optically active N-protected .alpha.-amino aldehydes in organic synthesis , 1989 .
[8] D. Carson,et al. Effect of neuropeptides on production of inflammatory cytokines by human monocytes , 1988 .
[9] M. Otsuka,et al. Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord‐tail preparation of the newborn rat. , 1988, The Journal of physiology.
[10] D. Carson,et al. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. , 1987, Science.